Abstract
Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.
| Original language | Italian |
|---|---|
| Pages (from-to) | 539-543 |
| Number of pages | 5 |
| Journal | Giornale Italiano di Cardiologia |
| Volume | 16 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Medicine(all)
Cite this
La biopsia endomiocardica nella miocardite acuta : Per alcuni ma non per tutti i pazienti. / Ammirati, Enrico; Cipriani, Manlio; Bonacina, Edgardo; Garascia, Andrea; Oliva, Fabrizio.
In: Giornale Italiano di Cardiologia, Vol. 16, No. 10, 01.10.2015, p. 539-543.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - La biopsia endomiocardica nella miocardite acuta
T2 - Per alcuni ma non per tutti i pazienti
AU - Ammirati, Enrico
AU - Cipriani, Manlio
AU - Bonacina, Edgardo
AU - Garascia, Andrea
AU - Oliva, Fabrizio
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.
AB - Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.
UR - http://www.scopus.com/inward/record.url?scp=84948149676&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84948149676&partnerID=8YFLogxK
U2 - 10.1714/2028.22034
DO - 10.1714/2028.22034
M3 - Articolo
C2 - 26444211
AN - SCOPUS:84948149676
VL - 16
SP - 539
EP - 543
JO - Giornale Italiano di Cardiologia
JF - Giornale Italiano di Cardiologia
SN - 1827-6806
IS - 10
ER -